Expanding sexual and gender minority research in movement disorders: More than awareness and acceptance.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
06 2021
Historique:
received: 22 03 2021
revised: 10 05 2021
accepted: 21 05 2021
pubmed: 6 6 2021
medline: 27 1 2022
entrez: 5 6 2021
Statut: ppublish

Résumé

Culturally competent and inclusive care is slowly becoming the standard throughout healthcare institutions. Awareness, acceptance, and inclusion of the sexual and gender minority (SGM) groups in medicine and neurology are progressing. Research in SGM health, although increasing, remains remarkably scant in parkinsonism and other movement disorders, a community whose patient population is on the rise. Most SGM health research in movement disorders only focuses on the symptoms associated with infection by the human immunodeficiency virus and the acquired immunodeficiency syndrome. Multiple clinical and epidemiological research questions remain unaddressed when considering the intersection of movement disorders and SGM health. In this article, we highlight gaps in the care of SGM individuals with movement disorders. First, the prevalence and phenomenology of movement disorders could be different, considering the different rates of risk factors and the use of gender-affirming hormones. Also, the effect of creating a safe environment in healthcare institutions to disclose sexual orientation and gender identity on seeking care, access to resources, and quality of services remains unknown. Moreover, many individuals with movement disorders would require services from multidisciplinary teams or long-term care facilities, which might not consider the needs of SGM patients in their models of care. Last, the effect of social isolation and self-perception (or misperceptions) in the SGM populations on the non-motor and motor symptoms of movement disorders and the treatment plans is not understood.

Identifiants

pubmed: 34088617
pii: S1353-8020(21)00190-5
doi: 10.1016/j.parkreldis.2021.05.019
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-165

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Chi-Ying Roy Lin (CR)

Department of Neurology, Columbia University Medical Center, New York, NY, USA.

Nicole Rosendale (N)

Department of Neurology, University of California San Francisco, CA, USA.

Wissam Deeb (W)

Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester, MA, USA. Electronic address: Wissam.Deeb2@umassmemorial.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH